Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
13.89
Dollar change
-0.30
Percentage change
-2.11
%
Index- P/E34.73 EPS (ttm)0.40 Insider Own0.02% Shs Outstand3.14B Perf Week-3.27%
Market Cap43.58B Forward P/E29.39 EPS next Y0.47 Insider Trans0.00% Shs Float3.14B Perf Month-5.19%
Income1.27B PEG1736.68 EPS next Q-0.01 Inst Own5.45% Short Float0.18% Perf Quarter-1.28%
Sales29.65B P/S1.47 EPS this Y-58.38% Inst Trans11.64% Short Ratio3.00 Perf Half Y-12.92%
Book/sh15.24 P/B0.91 EPS next Y50.41% ROA1.25% Short Interest5.50M Perf Year-15.51%
Cash/sh0.65 P/C21.31 EPS next 5Y0.02% ROE2.68% 52W Range13.19 - 17.15 Perf YTD-2.66%
Dividend Est.0.63 (4.53%) P/FCF12.51 EPS past 5Y-6.94% ROI1.62% 52W High-19.01% Beta0.57
Dividend TTM0.63 (4.53%) Quick Ratio0.55 Sales past 5Y15.39% Gross Margin52.34% 52W Low5.31% ATR (14)0.21
Dividend Ex-DateSep 28, 2023 Current Ratio1.06 EPS Y/Y TTM-36.97% Oper. Margin11.07% RSI (14)37.10 Volatility0.92% 0.91%
Employees49095 Debt/Eq0.69 Sales Y/Y TTM-1.17% Profit Margin4.28% Recom2.20 Target Price16.19
Option/ShortYes / Yes LT Debt/Eq0.64 EPS Q/Q-15.92% Payout73.71% Rel Volume0.81 Prev Close14.19
Sales Surprise10.82% EPS Surprise132.55% Sales Q/Q-3.11% EarningsFeb 01 AMC Avg Volume1.84M Price13.89
SMA20-4.05% SMA50-4.32% SMA200-6.33% Trades Volume1,484,599 Change-2.11%
Date Action Analyst Rating Change Price Target Change
Mar-16-23Upgrade BofA Securities Neutral → Buy $20
Jul-19-22Upgrade Cowen Market Perform → Outperform $21 → $24
Oct-07-21Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-19-21Downgrade JP Morgan Overweight → Neutral
Nov-01-19Initiated Cowen Market Perform $19.50
Aug-15-19Downgrade Daiwa Securities Outperform → Neutral
Mar-27-24 08:56AM
Mar-26-24 07:07PM
08:00AM
Mar-19-24 12:20PM
06:30AM
02:15AM Loading…
Mar-14-24 02:15AM
Mar-13-24 08:00AM
Mar-11-24 12:00PM
09:40AM
Mar-09-24 01:07PM
Feb-26-24 11:30PM
11:30PM
07:00AM
Feb-24-24 05:06AM
Feb-23-24 05:43AM
06:56AM Loading…
Feb-21-24 06:56AM
Feb-12-24 08:32AM
08:10AM
08:00AM
Feb-10-24 08:30AM
Feb-09-24 07:08AM
Feb-08-24 06:00PM
Feb-01-24 06:35AM
01:54AM
01:47AM
01:02AM
Jan-31-24 07:19PM
04:05PM
Jan-29-24 11:10AM
02:00AM
05:00PM Loading…
Jan-25-24 05:00PM
04:52PM
Jan-18-24 07:00AM
Jan-16-24 08:00AM
Dec-22-23 05:35AM
Dec-21-23 04:00PM
Dec-20-23 07:01AM
Dec-19-23 11:41AM
Dec-15-23 08:16AM
Dec-12-23 03:04PM
Dec-11-23 10:24AM
Dec-07-23 09:40AM
Dec-05-23 08:00AM
Nov-27-23 08:00AM
Nov-17-23 09:40AM
Nov-16-23 07:47PM
Nov-09-23 03:50PM
03:50PM
03:06PM
08:38AM
07:00AM
Nov-08-23 05:54PM
Nov-07-23 10:00AM
Oct-27-23 01:10PM
11:40AM
Oct-26-23 08:37PM
04:44AM
02:00AM
Oct-19-23 10:32AM
Oct-18-23 04:30PM
Oct-17-23 07:30PM
07:30PM
Oct-05-23 01:33PM
Oct-03-23 04:50PM
07:00AM
Oct-02-23 06:26PM
05:07PM
04:30PM
10:34AM
Sep-29-23 04:30AM
Sep-27-23 04:25PM
Sep-25-23 04:08PM
08:44AM
Sep-20-23 08:00AM
Sep-13-23 10:00AM
08:00AM
Sep-12-23 08:30AM
Sep-11-23 06:45AM
Sep-06-23 12:09PM
Aug-31-23 03:33PM
Aug-28-23 03:26PM
Aug-27-23 12:00AM
Aug-25-23 09:40AM
Aug-24-23 05:00PM
Aug-23-23 02:22PM
Aug-08-23 09:42AM
09:13AM
Jul-27-23 02:27AM
02:00AM
Jul-26-23 05:11PM
09:40AM
Jul-21-23 12:18PM
Jul-12-23 10:32AM
Jul-11-23 11:23AM
10:36AM
Jun-25-23 10:45AM
Jun-21-23 04:23PM
Jun-20-23 08:45AM
Jun-15-23 08:30PM
08:00PM
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TAKEDA PHARMACEUTICAL CO LTD10% OwnerJan 24 '24Sale8.103,703,70329,999,9943,755,583Jan 25 06:13 AM